- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Case Reports in Medicine
Volume 2010 (2010), Article ID 982521, 4 pages
Pneumococcal Tricuspid Valve Endocarditis in a Young African American: A Case for Inclusion of African Americans in Pneumococcal Vaccine Criteria
1Department of Internal Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Boulevard, Nashville, TN 37208, USA
2Department of Internal Medicine, Aultman Hospital, 2600 6th st SW, Canton, OH 44710, USA
3Department of Cardiology, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Boulevard, Nashville, TN 37208, USA
Received 22 June 2010; Accepted 23 August 2010
Academic Editor: Grigorios Korosoglou
Copyright © 2010 Oghenerukevwe Odiete et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Following the development of penicillin, complications from streptococcus pneumonia such as endocarditis have become rare. However, certain independent risk factors such as cigarette smoking and being of African-American (AA) decent have been associated with a higher incidence of invasive pneumococcal disease, but only cigarette smoking has been targeted by current recommendations from the Advisory Committee on Immunological Practices (ACIPs). We report a case of a young AA smoker, who developed an isolated tricuspid valve pneumococcal endocarditis. This case will illustrate the high susceptibility for invasive pneumococcus sequelae in AA, thereby raising the argument for the consideration of AA in the Pneumococcal Conjugate Vaccine (PCV) criteria, regardless of smoking history.
Isolated tricuspid valve endocarditis is usually seen in intravenous drug users and patients with abnormal or prosthetic heart valves . Since the introduction of penicillin, streptococcus pneumoniae has been an uncommon cause of bacterial endocarditis accounting for less than 5% of all the cases of endocarditis . Cigarette smoking and being of an AA ethnicity are strong independent risk factors for invasive pneumococcal disease in the nonelderly and immunocompetent patients . The rate of invasive pneumococcal disease in AA of all ages has at least twice the risk in the white population in the United States [4, 5]. Pneumococcal bacteremia could lead to complications such as endocarditis . We report a case of an isolated tricuspid valve endocarditis due to PSSP in a nonelderly AA chronic smoker without any other additional risk factors.
2. Case Presentation
A 27-year-old African-American female, presented with complaints of cough and vomiting for the past two weeks. The patient was seen in the emergency room one week prior with similar problems and was sent home on oral levafloxacin and ibuprophen for CAP. Despite being on oral antibiotics, the patient did not improve and returned to the hospital with similar complaint in addition to a fever and a cough with whitish-yellow sputum production. The patient did not report any history of surgical, dental, or genitourinary procedures prior to the emergence of her symptoms. She also had no history of congenital cardiac disease, systemic lupus erythematosus, or rheumatic fever. She smoked one pack of cigarettes per day for 11 years, occasionally used marijuana and had no history of alcohol or intravenous drug use.
On physical exam, her temperature was 102.8 F, heart rate was 98 bpm, respiratory rate was 34 rpm, and her blood pressure was 157/97 mmHg. On heart auscultation, the rhythm and rate were normal. S1 and S2 sounds were present. There was a grade 2/6 mid-systolic murmur heard best in the left lower sternal border, nonradiating, which was new when compared with the previous visit to the emergency department. The point of maximal impact (PMI) was nondisplaced. On lung exam, faint crackles were heard on the right side. The remaining physical examination was within the normal limit.
The laboratory results showed a white blood cell count of 26.1 k/cumm, hemoglobin 10.7 g/dL, and hematocrit 31.3%. The Urinalysis and urine drug screen was negative. Two separate sets of blood cultures were positive for Streptococcus pneumonia sensitive to penicillin (MIC ). The Sputum culture was negative. The chest X-ray showed a right middle lobe infiltrate. Trans-thoracic echocardiogram (Figure 1) showed a 2.2 1.6 cm pedunculated vegetation, noted on the base of the posterior cusp of the tricuspid valve with moderate tricuspid regurgitation. The ejection fraction was 55%. The diagnosis of PSSP endocarditis was made and the patient was started on IV ceftriaxone.
On the second day of admission, the patient started complaining of left pleuritic chest pain, dyspnea, and hemoptysis. Given the fact that the patient had valvular vegetations, a CT scan (Figure 2) was done to rule out pulmonary septic embolism. The CT scan showed cavitary and noncavitary small nodular lesions consistent with pulmonary septic embolization and a lingular pneumonia. After seven days of treatment, pyrexia persisted and gentamicin was added to the regimen. Patient remained afebrile for the next 72 hours and was discharged to complete a six-week course of antibiotics.
The risk for invasive pneumococcal disease has been shown to vary between ethnic groups. Previous studies have identified African-American ethnicity as an independent risk factor for invasive pneumococcal disease with odds ratio of 3.4 in a study by Nuorti et al.  and of 4.6 in a study by Lexau et al. . The rate of invasive pneumococcal disease in AA of all ages is about twice more frequent than in the white population in the United States [5, 6]. Although, cigarette smoking has been noted as a strong risk factor for invasive pneumococcal disease, the fact that this patient is AA significantly increases her overall risk.
A mechanism to explain the etiology of endocarditis in this young AA smoker could be that the patient had nasopharyngeal pneumococcal colonization, which is usually increased in both AA and smokers . Following breach of the mucosal barriers—perhaps due to a viral infection—the patient developed invasive disease (bacteremia), and then secondary spread to the tricuspid valve. It is also conceivable that the invasive pneumococcus was either causative or as a result of the patients’ pulmonary infection. Pneumococcal bacteremia can occur in patients with or without pneumococcal pneumonia and it can also occur in both immunocompetent and immunosuppressed individuals.
Most cases of isolated endocarditis of the tricuspid valve have been associated with intravenous drug use, intracardiac catheterization, cardiac anomalies, immunodeficiency, and indwelling central venous lines . Tricuspid valve lesions tend to be attributed to Staphylococcus infections [8, 9] with pneumococcus being an uncommon causative organism . In a review article of 197 patients with pneumococcal endocarditis, 10 patients (8.3%) had tricuspid valve involvement . What made our patient unique are not the individual diagnostic findings but the aggregate clinical picture. This patient had isolated right heart involvement, which is less common than left-sided lesions. Also, the organism involved in this patient was penicillin sensitive pneumococcus (penicillin resistant species are more commonly reported [12, 13]). Furthermore, the patient also lacked the common risk factors frequently associated with tricuspid valve disease, which include chronic alcoholism and heart valve abnormalities.
Due to the fact that pneumococcal bacteremia can lead to such serious complications such as endocarditis, which carries significant morbidity and mortality, it should be treated with vigilance. The Advisory Committee on Immunological Practices (ACIPs) recommends that Alaska Natives and American Indians of all ages should receive pneumococcal polysaccharide vaccine, if they are living in area in which the risk of invasive pneumococcal diseases is increased . Current provisional recommendations do not include African-American adults aged 65 years without underlying illnesses. Even though we concede that this patient would have qualified for the vaccine because she is a smoker, we can also argue that evidence suggests she is a candidate by virtue of simply being AA. The cumulative risk of being an AA smoker should be treated with more vigilance and when these patients are identified in our clinics and emergency rooms. We must be assertive in encouraging them to receive vaccinations to prevent serious illness. PCV have resulted in the decrease of invasive pneumococcal disease in children, the elderly [15, 16], and should be considered for all patients at risk for invasive pneumococcal disease, which includes young AA.
Streptococcal pneumoniae is a rare cause of endocarditis, which rarely affects the tricuspid valve. A high index of suspicion for bacterial endocarditis should be applied in all patients, especially AA and smokers in the setting of pneumococcal bacteremia. Prudent auscultation for new murmurs in such patients must be executed judiciously. An echocardiogram might be indicated in a patient with pneumococcal pneumonia who is not responding to appropriate antibiotics to rule out endocarditis. Finally, it is worthy of debate that the inclusion of African Americans to the PCV vaccination criteria be considered to prevent the occurrence of pneumococcal bacteremia and its complications.
The authors declare that they have no competing interests.
O. Odiete conceived the study, substantially involved in the acquisition of data, compilation of relevant literature, and drafted the preliminary and final paper. O. Akinwande was involved intellectually in the revision, formatting and proofreading the paper. J. Murray was involve in some relevant literature compilation, and proofreading of the paper. J. Akamah was the cardiologist on consult, read the echocardiogram, and was involved in the provisional and final diagnosis. He also reviewed the paper. All authors have read and approved the final version of the paper.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- R. Nandakumar and G. Raju, “Isolated tricuspid valve endocarditis in nonaddicted patients: a diagnostic challenge,” American Journal of the Medical Sciences, vol. 314, no. 3, pp. 207–212, 1997.
- V. Ugolini, A. Pacifico, T. C. Smitherman, and P. A. Mackowiak, “Pneumococcal endocarditis update: analysis of 10 cases diagnosed between 1974 and 1984,” American Heart Journal, vol. 112, no. 4, pp. 813–819, 1986.
- J. P. Nuorti, J. C. Butler, M. M. Farley et al., “Cigarette smoking and invasive pneumococcal disease,” The New England Journal of Medicine, vol. 342, no. 10, pp. 681–689, 2000.
- C. A. Lexau, R. Lynfield, R. Danila et al., “Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine,” Journal of the American Medical Association, vol. 294, no. 16, pp. 2043–2051, 2005.
- P. Pastor, F. Medley, and T. V. Murphy, “Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995,” Clinical Infectious Diseases, vol. 26, no. 3, pp. 590–595, 1998.
- Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report. Emerging Infections Program Network, “Streptococcus pneumoniae 1999,” http://www.cdc.gov/abcs/reports-findings/survreports/spneu99.html.
- D. Greenberg, N. Givon-Lavi, A. Broides, I. Blancovich, N. Peled, and R. Dagan, “The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers,” Clinical Infectious Diseases, vol. 42, no. 7, pp. 897–903, 2006.
- J. F. Varona and J. M. Guerra, “Tricuspid valve endocarditis in a nonaddicted patient without predisposing myocardiopathy,” Revista Espanola de Cardiologia, vol. 57, no. 10, pp. 993–996, 2004.
- D. P. Naidoo, “Right-sided endocarditis in the non-drug addict,” Postgraduate Medical Journal, vol. 69, no. 814, pp. 615–620, 1993.
- P. Chan, J. D. Ogilby, and B. Segal, “Tricuspid valve endocarditis,” American Heart Journal, vol. 117, no. 5, pp. 1140–1146, 1989.
- S. I. Aronin, S. K. Mukherjee, J. C. West, and E. L. Cooney, “Review of pneumococcal endocarditis in adults in the penicillin era,” Clinical Infectious Diseases, vol. 26, no. 1, pp. 165–171, 1998.
- J. E. Bothwell, F. Casey, and C. H. Webb, “Tricuspid valvar endocarditis caused by penicillin resistant pneumococcus,” Cardiology in the Young, vol. 11, no. 5, pp. 556–558, 2001.
- M. Siegel and J. Timpone, “Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review,” Clinical Infectious Diseases, vol. 32, no. 6, pp. 972–974, 2001.
- L. J. McKibben, P. V. Stange, V. P. Sneller, R. A. Strikas, and L. E. Rodewald, “Use of standing orders programs to increase adult vaccination rates: recommendations of the Advisory Committee on Immunological Practices,” MMWR: Morbidity and Mortality Weekly Report, vol. 49, no. 1, pp. 15–16, 2000.
- K. A. Robinson, W. Baughman, G. Rothrock et al., “Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998 opportunities for prevention in the conjugate vaccine era,” Journal of the American Medical Association, vol. 285, no. 13, pp. 1729–1735, 2001.
- W. C. Albrich, W. Baughman, B. Schmotzer, and M. M. Farley, “Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine,” Clinical Infectious Diseases, vol. 44, no. 12, pp. 1569–1576, 2007.